Dosing (SAA)
Dosing (SAA) Revolade Dosage and Administration in Severe Aplastic Anemia
Initial dosing regimen:
Revolade should be initiated concurrently with standard immunosuppressive therapy...
Initial dosing regimen:
Revolade should be initiated concurrently with standard immunosuppressive therapy...
REVOLADE Can Offer Convenient Dose Regimen With Flexible Dose Adjustments
*For patients of East-Asian ancestry, REVOLADE should be initiated at a reduced dose of 25 mg...
Indications 1
Kisqali is indicated in combination with an aromatase inhibitor as initial endocrine-based therapy for the treatment of pre/perimenopausal or...
Mechanism of Action 1
Ribociclib is a selective inhibitor of cyclin-dependent kinase (CDK) 4 and 6. These kinases are activated upon binding to D-cyclins and...
1L, first-line; 2L, second-line; aBC, advanced breast cancer; CDK4/6i, cyclin-dependent kinase 4/6 inhibitor; CI, confidence interval; ET, endocrine therapy; FUL,...